Nebu~flow

Transforming Respiratory Drug Delivery

  • Biotech
Therapeutics

Member

Active

Status

2019

Founded

Development stage

  • SCVC

Nebu-Flow is developing next-generation nebulisers to deliver life-changing, inhaled treatments for patients with respiratory disorders. Its patented aerosol formation technology overcomes current treatment limitations by accurately controlling drug droplet size for effective deep lung deposition, avoiding blockages in the upper respiratory tract. This paves the way for the injection-free delivery of previously hard-to-nebulise drugs and vaccines, expanding treatment possibilities for cardivascular and central nerve system disorders.

Founding team

Key contacts

Scientific Advisor